{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:51Z","timestamp":1761561771557},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/hjh.0b013e328362152e","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T11:36:57Z","timestamp":1370518617000},"page":"1662-1668","source":"Crossref","is-referenced-by-count":45,"title":["Eligibility for percutaneous renal denervation"],"prefix":"10.1097","volume":"31","author":[{"given":"Willemien L.","family":"Verloop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva E.","family":"Vink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Voskuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evert-jan","family":"Vonken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten B.","family":"Rookmaaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel L.","family":"Bots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilko","family":"Spiering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-24-20210208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data.","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"R2-24-20210208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"R3-24-20210208","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/HJH.0b013e3283282f65","article-title":"Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries.","volume":"27","author":"Pereira","year":"2009","journal-title":"J Hypertens"},{"key":"R4-24-20210208","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.109.138610","article-title":"Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.","volume":"54","author":"Schlaich","year":"2009","journal-title":"Hypertension"},{"key":"R5-24-20210208","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension.","volume":"361","author":"Schlaich","year":"2009","journal-title":"N Engl J Med"},{"key":"R6-24-20210208","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"R7-24-20210208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"R8-24-20210208","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"1 InvestigatorsCatheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.","volume":"57","author":"Symplicity","year":"2011","journal-title":"Hypertension"},{"key":"R9-24-20210208","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJH.0b013e328352ce78","article-title":"ESH position paper: renal denervation: an interventional therapy of resistant hypertension.","volume":"30","author":"Schmieder","year":"2012","journal-title":"J Hypertens"},{"key":"R10-24-20210208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R11-24-20210208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"R12-24-20210208","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"R13-24-20210208","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0b013e328353634e","article-title":"Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.","volume":"30","author":"Sierra de la SA, Banegas","year":"2012","journal-title":"J Hypertens"},{"key":"R14-24-20210208","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients.","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"R15-24-20210208","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003-2008.","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"R16-24-20210208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"R17-24-20210208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejim.2011.05.004","article-title":"Endocrine hypertension: current understanding and comprehensive management review.","volume":"22","author":"Sukor","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R18-24-20210208","first-page":"1471","article-title":"Diagnosis of secondary hypertension: an age-based approach.","volume":"82","author":"Viera","year":"2010","journal-title":"Am Fam Physician"},{"key":"R19-24-20210208","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1136\/bmj.e181","article-title":"NICE hypertension guideline 2011: evidence based evolution.","volume":"344","author":"McManus","year":"2012","journal-title":"BMJ"},{"key":"R20-24-20210208","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjmed.2009.05.020","article-title":"Discrepancies between office and ambulatory blood pressure: clinical implications.","volume":"122","author":"Banegas","year":"2009","journal-title":"Am J Med"},{"key":"R21-24-20210208","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00126097-199904000-00009","article-title":"Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.","volume":"4","author":"Waeber","year":"1999","journal-title":"Blood Press Monit"},{"key":"R22-24-20210208","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.HYP.17.6.1057","article-title":"Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.","volume":"17","author":"Miyajima","year":"1991","journal-title":"Hypertension"},{"key":"R23-24-20210208","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-24-20210208","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"R25-24-20210208","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.","volume":"73","author":"McKenna","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-24-20210208","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after nonselective screening of hypertensive patients.","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"R27-24-20210208","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-24-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med"},{"key":"R29-24-20210208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004424-200001000-00004","article-title":"Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure.","volume":"35","author":"Tombach","year":"2000","journal-title":"Invest Radiol"},{"key":"R30-24-20210208","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular hypertension and ischemic nephropathy.","volume":"23","author":"Textor","year":"2010","journal-title":"Am J Hypertens"},{"key":"R31-24-20210208","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.jacc.2012.08.1002","article-title":"Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.","volume":"60","author":"Savard","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R32-24-20210208","first-page":"1159","article-title":"Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude.","volume":"8","author":"Muller","year":"2012","journal-title":"Rev Med Suisse"},{"key":"R33-24-20210208","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1055\/s-0031-1272580","article-title":"Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment.","volume":"136","author":"Mahfoud","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"key":"R34-24-20210208","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.acvd.2012.03.005","article-title":"Expert consensus: renal denervation for the treatment of arterial hypertension.","volume":"105","author":"Pathak","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"R35-24-20210208","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fphys.2012.00029","article-title":"Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity.","volume":"3","author":"Vink","year":"2012","journal-title":"Front Physiol"},{"key":"R36-24-20210208","first-page":"2732","article-title":"Renal denervation: potential impact on hypertension in kidney disease Nephrol Dial T","volume":"26","author":"Blankestijn","year":"2011","journal-title":"ransplant"},{"key":"R37-24-20210208","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.hjr.0000160601.41762.44","article-title":"Adherence to antihypertensive treatment: a critical factor for blood pressure control.","volume":"12","author":"Yiannakopoulou","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e328362152e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:41:15Z","timestamp":1621885275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201308000-00024"}},"subtitle":["the importance of a systematic screening"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328362152e","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}